Epigenetic silencing of the interferon regulatory factor ICSBP/IRF8 in human multiple myeloma
Authors:
- Helena Jernberg-WiklundHJHelena Jernberg-Wiklund
- Kenneth NilssonKNKenneth Nilsson
- Fredrik ÖbergFÖFredrik Öberg
- 1 December 2008
- journal article
- research article
- Published by Elsevier in Experimental Hematology
- Vol. 36 (12) , 1673-1681.e1
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Repression of IFN Regulatory Factor 8 by DNA Methylation Is a Molecular Determinant of Apoptotic Resistance and Metastatic Phenotype in Metastatic Tumor CellsCancer Research, 2007
- A stem cell–like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencingNature Genetics, 2007
- Inhibition of Monocytic Differentiation by Phosphorylation‐deficient Stat1 is Associated with Impaired Expression of Stat2, ICSBP/IRF8 and C/EBPɛScandinavian Journal of Immunology, 2006
- The epigenetic progenitor origin of human cancerNature Reviews Genetics, 2006
- IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte developmentGenes & Development, 2003
- Regulation of Apoptosis in Myeloid Cells by Interferon Consensus Sequence–Binding ProteinJournal of Experimental Medicine, 1999
- Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myelomaNature Genetics, 1997
- HUMAN PLASMACYTOMA WITH AN UNUSUAL KARYOTYPE GROWING IN VITRO AND PRODUCING LIGHT-CHAIN IMMUNOGLOBULINThe Lancet, 1982
- Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2-producing human leukemia T cell line.Journal of Experimental Medicine, 1980
- Establishment and characterization of a human histiocytic lymphoma cell line (U‐937)International Journal of Cancer, 1976